Duloxetine
Product Images NDC 65841-776

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 65841-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Healthcare Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine Hydrochloride Delayed-release Capsules (Duloxetinecapsulemfg Figure 01)

FDA Label Image

Duloxetine Hydrochloride Delayed-release Capsules (Duloxetinecapsulemfg Figure 02)

FDA Label Image

Duloxetine Hydrochloride Delayed-release Capsules (Duloxetinecapsulemfg Figure 03)

FDA Label Image

Duloxetine Delayed-release Capsules, 20 mg (Duloxetinecapsulemfg Figure 04)

This is a description of DULOXETINE DELAYED-RELEASE Capsules, USP 49 manufactured by ZyGenerics. The capsules contain 224 mg of doxeine hyrchiaide, USP. The recommended dosage is mentioned in the package insert. The drug should be stored at 20°- 25°C and should be kept out of the reach of children. It is manufactured by Cadia Healthcare Ltd in Amedabad, India.*

FDA Label Image

Duloxetine Delayed-release Capsules, 30 mg (Duloxetinecapsulemfg Figure 05)

This is a description of a medication called Duloxetine, which is available in the form of delayed-release capsules. Each capsule contains 0.7mg of Duloxetine hydrochloride, equivalent to 30mg of Duloxetine. The usual dosage and prescribing information are available in the package insert. The medication should be stored at controlled room temperature and dispensed in a tight container. It is manufactured by Cadia Healthcare Ltd. in Ahmedabad, India. It is important to keep this and all drugs out of the reach of children.*

FDA Label Image

Duloxetine Delayed-release Capsules, 60 mg (Duloxetinecapsulemfg Figure 06)

This is a description of a medication called Duloxetine, delayed-release capsules USP. The capsules contain 67.3 mg of duloxetine hydrochloride, which is equivalent to 50 mg of duloxetine. The medication guide must be provided to each patient. It is recommended to store the medication at a controlled room temperature of 20°C to 25°C. It is important to keep this and all medication out of the reach of children. The medication is manufactured by Cadia Healthcare Ltd. located in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.